Adult Dosing .
Dosage forms: 1
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
breast CA, advanced or metastatic postmenopausal
- [1 mg PO qd]
early postmenopausal breast CA, adjuvant tx
- [1 mg PO qd]
- [1-5 mg PO qd x5 days]
- Start: day 3 of menstrual cycle
- [no adjustment]
- [see below]
- mild-mod impairment/cirrhosis: no adjustment; severe impairment: not defined
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.
- hypersens. to drug/class/compon.
- premenopausal pts
- caution if ischemic heart dz
Drug Interactions .
- estradiol (contraceptive)
- estradiol (hormone replacement)
- estrogens, conjugated (hormone replacement)
- estrogens, esterified (hormone replacement)
- estropipate (hormone replacement)
- ethinyl estradiol (contraceptive)
- ethinyl estradiol (hormone replacement)
- mestranol (contraceptive)
Adverse Reactions .
- endometrial CA
- erythema multiforme
- Stevens-Johnson syndrome
- hot flashes
- weight gain
- abdominal pain
- bone pain
- breast pain
Lactation: Safety Unknown
pregnancy test at baseline; consider BMD, lipid panel
Look/Sound-Alike Drug Names
anastrozole confused with: anagrelide; letrozole
Metabolism: liver primarily; CYP450: none
Excretion: urine 60% (10% unchanged), feces; Half-life: 50h
Mechanism of Action
inhibits enzymatic androgen conversion to estrogen, reducing hormone receptor positive cancer cell growth (aromatase inhibitor)
Approximate Retail Price
- 1 mg (30 ea): $384.84
Join Now to View Patient Handouts!
Create a FREE Epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.